3594 results about "Formulary" patented technology

The anti-infective medicine, including powder, mixture, aerosol, capsule, injection, suppository, ointment and microcapsule, is characterized by that on the theroretical basis of combining traditional Chinese medicine and modern immunology the immunoglobulin, effective components of Chinese medicinal materials which are extracted according to the compound prescription and auxiliary preparation are combined together organically, and undergone the fine preparation process to obtain a high-efficiency, safe, stable, environment-protecting type anti-infection medicine having no toxic side effect and having no drug resistance.

A solid drug solution perforator (SSP) system and an associated drug reservoir are provided for delivering therapeutic, prophylactic and / or cosmetic compounds, for nutrient delivery and for drug targeting. For drug delivery, the SSP system includes an active drug ingredient and a matrix of perforator material that biodegrades or dissolves quickly upon contact with a patient's body. The SSP system provides a skin barrier perforator and a controller for prompt initiation and cut-off drug delivery. In a preferred method of transdermal drug delivery, an SSP system containing a selected drug penetrates into an epidermis or dermis, and the drug is promptly released from the (dissolving) SSP system perforator. An additional drug is optionally delivered from a patch reservoir through skin pores created by insertion of the perforator. Formulation and fabrication procedures for the SSP and associated reservoir are also provided. An SSP system can be fabricated with variety of shapes and dimensions.

The automated drug discrimination system inspects the drug being dispensed during the dispensing process so that the pharmacist can be certain the correct formulation, dosage and quality of pharmaceuticals were dispensed so the pharmacist does not need to spend as much time examining the dispensed drug. The pills are dispensed through a dispensing area using a dispensing apparatus and are collected in a collection area. At least two sensors take a plurality of measurements of an aggregate of the pills during the dispensing process or of each pill as it moves through the dispensing area. A discrimination system compares the measurements taken to verify that the pills dispensed are the type of pharmaceuticals intended to be dispensed as identified in the individual prescription for at least one of formulation and dosage of the pill.

A container and method are provided for storing fat containing liquid products, such as infant or baby formula, or other milk-based products. The container includes a body defining a storage chamber for receiving the aseptic fat containing liquid product, and a first aperture in fluid communication with the storage chamber. The body does not leach more than a predetermined amount of leachables into the fat containing liquid product and does not undesirably alter a taste profile of the fat containing liquid product. A container closure assembly includes a stopper receivable within the first aperture for hermetically sealing the storage chamber. The stopper includes a first material portion defining an internal surface in fluid communication with the storage chamber forming at least most of the surface area of the container closure that can contact any fat containing liquid product within the storage chamber and that does not leach more than a predetermined amount of leachables into the fat containing liquid product or undesirably alter a taste profile of the fat containing liquid product. A second material portion of the stopper either (i) overlies the first material portion and cannot contact any product within the storage chamber, or (ii) forms a substantially lesser surface area of the container closure that can contact any product within the storage chamber in comparison to the first material portion. The second material portion is needle penetrable for filling the storage chamber with product, and a resulting needle aperture formed in the second material portion is thermally resealable such as by the application of laser energy to seal the product within the storage chamber. A sealing portion of the container closure is engageable with the body prior to needle filling the storage chamber to thereby form a substantially dry hermetic seal between the container closure and body.

Disclosed is an extended or controlled release dosage form of citalopram or its related forms and other newer antidepressants for oral administration to treat chronic patients suffering from depression and to minimize the side effects associated with the current drug treatment.

Robust sustained release formulations, solid dosage forms comprising robust sustained release formulations, and methods for making and using these formulations and solid dosage forms are provided. Robustness of the sustained release formulation is related to the particle size of the hydrophilic gum. Sustained release formulations resist dose-dumping when ingested with alcohol. The formulations are useful for treating a patient suffering from a condition, e.g., pain. The formulations comprise at least one drug. In one embodiment, the drug is an opioid, e.g., oxymorphone.

A device for preparing a fluid food at a desired consumption temperature on demand, comprising two reservoirs of water, a container containing a formula, a data processor and a controller for dispensing water of the correct temperature from each of the reservoirs and the formula from the container into a vessel. Also provided is a method to prepare a fluid food at a desired consumption temperature on demand.

New compositions formed from the combination of an active substance with a hydrogel carrier moiety are provided. The compositions are suitable for use in high-velocity transdermal particle injection techniques. Methods of providing the new compositions are also provided. In addition, methods for administering pharmacologically active agent to a subject are provided. These methods are useful for delivering drugs, biopharmaceuticals, vaccines and diagnostics agents.

The invention discloses a Chinese medicinal plaster for curing orthopaedics disease and the preparing method thereof, characterized by that it uses several ones of black-bone chicken, Chinese Angelica, Notoginseng powder,Myrrha, Rhizoma Drynariae, Dragon's Blood, Radix Curcumae, Common Burreed Rhizome, Zedoary, Giant Knotweed Rhizome, Ground Beeltle, Pyrite, and Frankincense as principal drugs and selects parts of 97 Chinese drugs such as Long-nosed Pit Viper, Earthworm, Dragon's Blood, Prepared ChuanWu, Pangolin Scales, Doubleteeth Pubesscent Angelica Root, Rhizoma Corydalis, Himalayan Teasel Root, Cortex Cinnamomi Cassiae, Flos Caryophylli, and Borneol as adjuvant drugs, according to different properties of Chinese drugs, fries partial medicinal materials, decocts partial light and strongly fibrous medicinal materials with water for three times, concentrates the decoction into extract, dries and crushes the extract into fine powder, and adds the fine powder into medicinal oil added with pills; and finally adds in powder of partial fine materials. Its formula and preparing method are peculiar and it is an ideal traditional external drug preparation for curing orthopaedics disease.

To maximize and maintain the antioxidant or pro-oxidant state for foods, beverages, personal care products, cosmetics, nutritional supplements, reagents, analytical standards, medical device formulations, pharmaceutical preparations or drags, the present invention discloses methods and devices to control redox equilibrium of such preparations throughout the processing steps and storage prior to, or at, the time of administration or use. The preparations (solid or liquid form) can then be stored in a redox-controlled container, package or applicator as described in the specification. Foods, beverages, personal care products, cosmetics, nutritional supplements, reagents, analytical standards, medical device formulations, pharmaceutical preparations and drugs stored in reactive oxidation states can be activated and stabilized by electrical voltages applied with a small battery and electrodes designed into the applicator, container or package.

A system and method for an adjustable bio-stream self-selecting system. Through a plethora of inputs, the system associates therapeutic recipes and associated biomarker in a personalized approach to recommending an individual to a specific therapeutic program. Therapeutic programs operate in accordance with personalized inputs suggested by the user and through digital markers and biomarkers, which trigger new recommendations by “knowing” the individual. Each bio-stream contains information utilized within these biomarkers to trigger additional therapy recommendations. Because of the complexity of the plurality of inputs, these biomarkers are managed in a way that enables low latency detections, low bandwidth needs, low processing needs, and less battery needs. The pre-processing of these biomarkers helps additional therapy management and precision medicine across larger global population needs of the system.

An apparatus for fabricating small compacts of formulations of a drug candidate, and a method for determining if a drug candidate, alone or in a formula mix, is suitable for dry granulation by a roller compactor based on physical measurements generated in part from such small compact.

A smart cap for a medical container for the containment of solid medications having unique indicia. The cap is provided with an optical scanner configured with at least one locally contained or external data base having general medication identification data and optionally patient-specific information to scan and identify the medication (and optionally the dosage, specific formulations, manufacturing source, etc.) and to record and correlate information regarding patient medication usage (scanning of a medication is generally considered indicative of actual patient taking of the medication). The cap further comprises communication elements configured to transmit / receive “usage” through scanning of a unit dosage of the medication, to an external data base such as the patient's cell phone and or computer (such as with blue tooth or RF communication) or via a telephone call or internet transmission to a data base of a pharmacy or physician or other health care provider.

The invention discloses a traditional Chinese medicine combination and a preparation method thereof for chronic enteritis treatment; the traditional Chinese medicine combination mainly includes the following raw medicines: crude radix astragali, Chinese yam, bighead atractylodes rhizome, rhizoma smilacis glabrae, honeysuckle, taraxacum officinale root, medicated leaven, burnt malt, atraotydin, mangnolia officinalis, dried tangerine or orange peel, plantain seed, scutellaria baicalensis, the rhizome of Chinese goldthread, limonite, semen euryales, fructus rosae laevigatae, liriope, fructus amomi, starwort root, schisandra, acorus gramineus, medlar, cyperus rotundus and the like The traditional Chinese medicine combination can be prepared into any type of common oral preparation according to the conventional traditional Chinese medicine preparation method. The invention can significantly improve the symptoms of chronic diarrhea, paroxysmal abdominal pain, dyspepsia, indigestion, loose stool, abdominal distension, emaciation, limb fatigue and doldrums, and also has definite clinical curative effect, significant curative and quick effect. As the traditional Chinese medicine combination basically combines medicinal and edible medicine sources specified in the National Formulary, the traditional Chinese medicine combination has low cost and basically has no toxic and side effect.

The invention discloses a plaster and a preparation method of the plaster. The crude drugs of the plaster include: 55-65g of Strychnos, 85-95g of radi of x clematidis, 40-50g of frankincense, 40-50g of myrrh, 25-35g of dragon's blood, 40 -50g of angelica, 25-35g of pseudo-ginseng, 45-55g of Ligusticum wallichii, 45-55g of Rhizoma Wenyujin Concisum, 40-50g of safflower, 45-55g of Processed Radix Aconiti, 45-55g of Processed Radix Aconiti Kusnezoffii, 55-65g of ephedra, 85-95g of cassia twig, 35-45g of notopterygium root, 35-45g of radix angelicae pubescentis, 55-65g of garden balsam stem, 45-55g of lycopodium clavatum, 35-45g of Rhizoma Drynariae, 45-55g of radix dipsaci, 45-55g of Eupolyphaga, 25-35g of scorpio, 40-50g of lumbricus, 40-50g of pangolin, 40-50g of Asarum and 15-25g of borneol. The formula is unique, the production method is simple and the curative effect is notable.

The invention belongs to the technical field of affinal drug and diet formulas and new resource food, and particularly provides blood fat-reducing medical science formula food, specific medical formula food or non-specific medical formula food. The formula food is prepared by performing reasonable compatibility on multiple affinal drug and diet traditional Chinese medicines according to the traditional Chinese medicine essence theory and mixing drug-diet dual purpose traditional Chinese medicine extract essence extracted through a semi-bionic extraction method, multiple microencapsulated probiotics, oligopeptides extracted through biological enzymolysis, prebiotics, amino acid, carbohydrate, fat with a health-care function, multiple vitamins and mineral substances according to the requirements of a 'special medial-purpose formula food general rule' by combining the constitutive characters of hyperlipidemia patients; the formula food not only can serve as a single nutrition source to meet the nutritional requirement of the hyperlipidemia patients, but also achieves the effects of reducing total cholesterol, reducing serum triglyceride, reducing an atherosclerosis index, reducing blood pressure, reducing blood sugar, reducing fat to lose weight and enhancing the immunity.

The present invention is directed to a new unit dose packaging for infant formula. The infant formula is manufactured as a tablet. One tablet will typically contain sufficient nutrients to produce a single serving of the formula (i.e. the amount of formula an average infant consumes in a single feeding). Other aspects of the invention are directed to feeding an infant such a reconstituted tablet and packaging containing such infant formula tablets.

A powdered, dispersible composition having stable dispersibility over time is provided. The composition exhibits a characteristic glass transition temperature (Tg) and a recommended storage temperature (Ts), wherein the difference between Tg and Ts is at least about 10° C. (i.e. Tg-Ts is greater than 10° C.). The composition comprises a mixture of a pharmaceutically-acceptable glassy matrix and at least one pharmacologically active material within the glassy matrix. It may be further mixed with a powdered, pharmaceutically-acceptable carrier. It is particularly valuable in unit dosage form having a moisture barrier, in combination with appropriate labelling instructions. A process for producing a powdered dispersible composition is also provided, wherein the process comprises removing the solvent from a solution comprising a solvent, a glass former and a pharmacologically active material under conditions sufficient to form a glassy matrix having the pharmacologically active material within the matrix.

The invention discloses a traditional Chinese medicine combination and a preparation method thereof for dysentery treatment; the traditional Chinese medicine combination mainly includes the following raw medicines: the rhizome of Chinese goldthread, bighead atractylodes rhizome, rhizoma atractylodis, mangnolia officinalis, medicated leaven, sunburn frankincense, sunburn myrrh, rhizoma alismatis, plantain seed, fructus evodiae, dried tangerine, angelica, white paeony root, scutellaria baicalensis, oyster, red halloysite, starwort root, rhizoma cyperi, gorgon fruit, Chinese yam, drgon's bones, radix sophorae flavescentis, ash bark and codonopsis pilosula and the like. The traditional Chinese medicine combination can be prepared into any type of common oral preparation according to the conventional traditional Chinese medicine preparation method. The invention can significantly improve the symptoms of diarrhea, dysentery, bellyache, tenesmus, dyspepsia, difficult diet and loss of appetite, and also has definite clinical curative effect, significant curative and quick effect. As the traditional Chinese medicine combination basically combines medicinal and edible medicine sources specified in the National Formulary, the traditional Chinese medicine combination has low cost and basically has no toxic and side effect.

Synergetic compounded medication formula for the treatment of psoriasis, seborrhea, dermatitis, dandruff, eczema, acne, and other skin disorders. The present invention is to provide regenerative treatment of skin disorders recurrent in all areas of the body. The invention of this disclosure uses a well-known corticosteroid as an active ingredient, namely Triamcinolone acetonide, which when used in combination with a special formula is effective, easy to use, and less expensive than similar products available with a prescription in the market. A method for administering said composition to inhibit proliferation of psoriatic cell populations in the epidermis is disclosed

The invention discloses a traditional Chinese medicine composition for treating colon cancer and a preparation method thereof. The traditional Chinese medicine composition mainly comprises the following raw medicinal herbs: indigo naturalis, tuckahoe, coix seed, taraxacum officinale root, herba violae, Mangnolia officinalis, houttuynia cordata, patrinia, angelica sinensis, radix paeoniae alba, Chinese lobelia herb, radix sophorae falvescentis, dried orange peel, medicated leaven, rhizoma cyperi, aspongopus, prepared frankincense, prepared myrrh, corydalis tuber, manis pentadactyla, raw astragalus mongholicus, radix notoginseng, charred sanguisorba officinalis, rhizoma sparganii, curcuma zedoary and the like. The Traditional Chinese medicine composition can be prepared into any one common oral preparation according to a conventional traditional Chinese medicine composition method. The invention can remarkably improve symptoms of frequency increase of defecate, blood and mucus brought in the defecate, bellyache, diarrhea or astriction, intestinal obstruction and malaise, weight reduction, anemia and the like, and has accurate clinical treatment effect, remarkable treatment effect and rapid effect taking. Because of being combined by basically adopting medicinal and edible medicines specified in National Formulary, the traditional Chinese medicine composition has the advantages of low cost, basic no toxic and side effect, and the like.

The invention relates to a wound repair hydrogel material, composed of the following components by parts by weight: 10-20 parts of synthesized hydrophilic polymer compound, 2-6 parts of chitosan quaternary ammonium salt and 100 parts of water. The preparation method of the wound repair hydrogel material includes that raw materials are heated and dissolved according to prescription requirement andthen are subject to standing or ultrasound defoaming, solution is poured into a specific mould, the mould is horizontally placed under the condition of 0-20 DEG C, self crosslinking is carried out for1-7 days, sealing is carried out, cobat-60 or electron accelerator is used for irradiation, and irradiation dosage is 10-100KGy. The prescription of the invention has the advantages that: the prescription is safer and more efficient, chitosan quaternary ammonium salt can be directly fused with other components without adding acid, thus preparation process is simper. The preparation method of theinvention has the advantage that: the obtained wound repair hydrogel material has both good flexibility and high transparency, thus being convenient for medical care personnel to observe wound surface.

Traditional Chinese medicine formula granules are a new product, can replace traditional Chinese medicine decoction pieces for compatibility of traditional Chinese medicine decoctions, have the advantages of being convenient, time-saving, land-saving, small-dosage, and the like, are increasingly welcomed by patients, and are undoubtedly a favorable to the people. But traditional Chinese medicine formula granules have no uniform national quality standards and no uniform industry standards, so that confusion in circulation and use of the traditional Chinese medicine formula granules is caused. With the release of production and application of the traditional Chinese medicine decoction piece granules, the confusion in circulation and use of the traditional Chinese medicine formula granules is more severe. A uniform, controllable and feasible quality standard for the traditional Chinese medicine formula granules is researched and established based on the confusion in circulation and use of the traditional Chinese medicine formula granules, and the uniform, controllable and feasible quality standard for the traditional Chinese medicine formula granules is facilitates normal and healthy development of the traditional Chinese medicine formula granules, and can ensure safe and effective drug use of the patients.

The present invention relates to a novel mucoadhesive composition for solubilization of insoluble drugs; its formulation including pharmaceutical compounds; and the preparation methods thereof wherein said solubilizing composition comprises 4˜90% by weight of at least one selected from the monoglycerides and 0.01˜90% by weight of at least one oil. The present invention relates to a novel mucoadhesive composition including pharmaceutical compounds; and the preparation methods thereof wherein said solubilizing composition including emulsifiers is composed of 4˜90% by weight of at least one selected from the monoglycerides, 0.01˜90% by weight, of at least one oil, and 0.01˜90% by weight of at least one selected from the emulsifiers. The compositions of the present invention is suitable as drug delivery systems since they exist as mucoadhesive liquid at physiological temperatures even though they exist as liquid or semi-solid at room temperature.

The invention relates to the technical field of traditional Chinese medicines, and in particular to a traditional Chinese medicine unguent for promoting blood circulation to remove meridian obstruction and a preparing method of the traditional Chinese medicine unguent. The traditional Chinese medicine unguent for promoting blood circulation to remove meridian obstruction mainly comprises the following raw materials: drynaria rhizome, radix clematidis, pawpaw, notopterygium root, radix angelicae tuhuo, radix saposhnikoviae, ligusticum wallichii, garden balsam stem, lycopodium clavatum, radix dipsaci, medicinal cyathula root, safflower carthamus, eucommia ulmoides, angelica sinensis, cassia twig, the root of common peony, rheum officinale, asarum, frankincense, myrrh, monkshood, radix aconiti agrestis, acacia catechu, ephedra, ground beeltle, lumbricus, stir-baked squama manitis, scorpio, pseudo-ginseng, daemonorops draco and borneol. The traditional Chinese medicine unguent is scientific in formula, and has the effects of promoting circulation and removing stasis, clearing and activating the channels and collaterals, dispelling wind to eliminate dampness, relieving swelling and pains and promoting reunion of fractured bones. The traditional Chinese medicine unguent is used for treating diseases such as lumbar disc herniation, traumatic injuries, fractures, osteoproliferation, arthritis, numbness of limb and femoral head necrosis, untoward effects are avoided, the traditional Chinese medicine unguent is safe, free of toxic and side effects and rapid in effect taking, treating both manifestation and root causes of the diseases, has a wide application prospect and market potential; and the total effective rate reaches 100%.

The invention discloses a Chinese medicine composition for treating headache and a preparation method thereof. The Chinese medicine composition is mainly formed by the following raw medicine materials: angelica root, Ligusticum wallichii, storax, snowbell, Rhizoma acori Graminei, holy basil, rheum officinale, Chinese angelica, white paeony root, red paeony root, immature bitter orange, rhizoma cyperi, notopterygium root, agilawood, dalbergia wood, Salvia miltiorrhiza Bunge, peach kernel, safflower, motherwort herb, pangolin scale and the like. The Chinese medicine composition of the invention can be prepared into any kind of common oral preparation according to the conventional Chinese medicine preparation method. The invention has the advantages that symptoms such as headache, parietal headache, medial headache and migraine, facial neuralgia, dysphoria, emotional instability, anxiety, insomnia, amnesia and the like are obviously improved, the clinical curative effect is exact, the curative effect is obvious and the rapid effect is obtained. Moreover, the Chinese medicine composition is basically combined by homologous plant food medicines regulated in National Formulary, thereby having the advantages of low cost, basically no toxic side effect and the like.

The present invention concerns drug formulae for nasal administration and insufflators filled with said formula. The present invention also concerns methods for making said formulae available as well as primary particles for obtaining chimerical agglomerates that can be used in said formulae.

The invention relates to a bagged preparation of health care wine and a preparation method thereof. The preparation method comprises steps of purifying large dosage and large volume of traditional wine preparing medicinal materials or foods in the formula so as to obtain an extractive only containing wine dissolving components, wherein the wine dissolving components of the medicinal materials or foods are easy to dissolve in wine; carrying out dehydration and anti-oxidation treatment on small dosage of medicinal materials or foods not easy to dissolve in wine, then smashing, sieving so as to obtain the powder, mixing the extractive only containing the wine dissolving components with the powder according to the preparation ratio of the health care wine, stoving, smashing, and then bagging. The bagged preparation of the health care wine effectively maintains effective components of the medicinal materials not easy to dissolve in wine, thus avoiding wasting; furthermore, the bagged preparations are packaged in vacuum, thus being convenient to carry and buy and mail.

The invention discloses a new traditional Chinese medicine composition for treating colonitis and a preparation method. The traditional Chinese medicine composition mainly comprises the following raw medicinal herbs: white atractylodes rhizome, tuckahoe, medicated leaven, red halloysite, Yaoli, myristica fragrans, plantain seed, charred cacumen biotae, dried orange peel, prepared frankincense, prepared myrrh, Mangnolia officinalis, fructus amomi, rhizoma atractylodis, radix sophorae falvescentis, scutellaria baicalensis, angelica sinensis, root of common peony, radix paeoniae alba, taraxacum officinale root, elbow, yam, herba cistanche and the like. The traditional Chinese medicine composition can be prepared into any one common oral preparation according to a conventional traditional Chinese medicine composition method. The invention can remarkably improve symptoms of diarrhea, bellyache, mucous stool and bloody purulent stool, tenesmus, even constipation for several days, irregularity of diarrhea and constipation, usually accompanied emaciation and acratia and the like, and has accurate clinical treatment effect, remarkable treatment effect and rapid effect taking. Because of being combined by basically adopting medicinal and edible medicines specified in National Formulary, the traditional Chinese medicine composition has the advantages of low cost, basic no toxic and side effect, and the like.